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The lateral habenula has been widely studied for its
contribution in generating reward-related behaviors
[1, 2]. We have found that this nucleus plays an unex-
pected role in the sedative actions of the general
anesthetic propofol. The lateral habenula is a gluta-
matergic, excitatory hub that projects to multiple tar-
gets throughout the brain, including GABAergic and
aminergic nuclei that control arousal [3–5]. When
glutamate release from the lateral habenula in mice
was genetically blocked, the ability of propofol to
induce sedation was greatly diminished. In addition
to this reduced sensitivity to propofol, blocking
output from the lateral habenula caused natural
non-rapid eye movement (NREM) sleep to become
highly fragmented, especially during the rest (‘‘lights
on’’) period. This fragmentation was largely reversed
by the dual orexinergic antagonist almorexant. We
conclude that the glutamatergic output from the
lateral habenula is permissive for the sedative ac-
tions of propofol and is also necessary for the
consolidation of natural sleep.
RESULTS AND DISCUSSION
Propofol is the most widely used intravenous (i.v.) general anes-
thetic, and its molecular target, the GABAA receptor, has long
been known [6–8]; however, the neuronal circuits that mediate
its sedative and anesthetic effects are a mystery [9]. In humans
and rodents, the effects of propofol on the electroencephalo-
gram (EEG) have been thoroughly characterized, with the key
feature being the increased coherence of thalamocortical oscil-
lations [10–12], with changes in the higher-order thalamic nuclei
correlating with loss of consciousness [10, 13]. But which
neuronal circuits trigger these changes? Because low-frequency
thalamocortical oscillations also increase during NREMsleep, an
obvious possibility was that propofol was directly affecting hypo-
thalamic nuclei involved in sleep and arousal [14, 15]. TheCurrent Biology 28, 1–8, F
This is an open access article undarousal-promoting histaminergic neurons in the hypothalamic
tuberomammillary nucleus have since been shown to be a plau-
sible target for GABAergic sedatives, such as zolpidem [16, 17],
and modulation of hypothalamic pathways has also been impli-
cated in the actions of volatile general anesthetics [18, 19].
During the sedation produced by systemically administered
GABAergic general anesthetics, as well as by the a2 adrenergic
agonist dexmedetomidine, cFOS expression increases in sleep-
promoting neurons and decreases in arousal-promoting neurons
[14, 20, 21]. A comprehensive study [22] surveyed cFOS expres-
sion throughout the brain in response to a variety of sedatives
and compared these changes with those observed during the
natural sleep-wake cycle. One remarkable observation in this
and a subsequent report [23] was that sedative agents induced
marked cFOS expression in the lateral habenula (LHb). Because
cFOS expression marks neuronal excitation, we have investi-
gated whether the sedative actions of propofol require neurons
of the LHb to be excited.
Propofol Selectively Induces cFOS Expression in the
LHb
We first confirmed that sedative doses of propofol do indeed
increase cFOS expression in the LHb above those induced
by saline injection (previous studies had used a variety of
GABAergic drugs but propofol has not itself been investigated
in this regard). Basal cFOS expression was found throughout
the brain, including in the neocortex and the midline thalamic
nuclei (Figure 1A; left panels). Figure 1A (right panels) also
shows that a sedative dose of propofol (212 ± 22 s of loss of
righting reflex; mean ± SD; n = 6) caused a marked expression
of cFOS in the LHb above the levels seen with a saline injection.
We explored the possibility that propofol might directly excite
LHb neurons but found that in acute slices from LHb-GFP
mice, 1.5 mM propofol, an appropriate concentration for loss
of righting reflex (LORR) [24], had no effect on the resting mem-
brane potential (Vm = 46.2 ± 2.1 mV for control, Vm = 46.6 ±
2.4 mV with propofol; n = 15, p = 0.59; paired two-tailed t test),
showing that the excitation must be by disinhibition elsewhere
in the circuitry. To investigate whether or not this propofol-
induced excitation (disinhibition) of the LHb was a cause or a
consequence of sedation, we sought to block the glutamatergicebruary 19, 2018 ª 2018 The Authors. Published by Elsevier Ltd. 1
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Figure 1. Propofol Induction of cFOS in the
LHb and Experimental Design
(A) The general anesthetic propofol induces
marked expression of c-FOS in the LHb (n = 6)
compared to saline injection (n = 4), showing
propofol activates the LHb. The images on the left
are representative brain sections stained for
c-FOS after saline injection. The images on the
right are representative brain sections stained for
c-FOS after propofol injection. PV, paraventricular
thalamic nucleus; 3V, third ventricle.
(B) The output from the LHb can be silenced by
expression of tetanus toxin light chain in LHb
neurons using Grm2-Cremice. Adeno-associated
viral (AAV) constructs expressing either GFP (AAV-
flex-GFP) or GFP-TeLC (AAV-flex-GFP-TeLC) in
Cre-positive neurons were injected bilaterally into
the LHb of Grm2-Cre mice. ITR, inverted terminal
repeats; CBA, chicken beta-actin promoter/
enhancer; LHb, lateral habenula; MHb, medial
habenula; pA, polyadenylation signal; WPRE,
woodchuck-postranscriptional-regulatory
element; scale bar, 500 mm.
(C) The extents of bilateral injections of AAV-flex-
GFP-TeLC into the LHb of Grm2-Cre mice along
the AP axis. The graph shows fluorescence in-
tensity across the LHb for GFP-TeLC mice
(means ± SEM; n = 19–32 sections from 4 mice).
See also Figures S1–S3.
Please cite this article in press as: Gelegen et al., Excitatory Pathways from the Lateral Habenula Enable Propofol-Induced Sedation, Current Biology
(2018), https://doi.org/10.1016/j.cub.2017.12.050output of the LHb to see whether this affected the sedative
actions of the drug.
Excitatory Output from the LHb Can Be Selectively
Blocked Using Grm2-Cre Mice and Tetanus Toxin Light
Chain
To selectively manipulate the LHb, we identified the metabo-
tropic glutamate receptor 2-Cre recombinase (Grm2-Cre)
mouse line, which has Cre recombinase expression in the
LHb, but not the medial habenula (MHb) (see STAR Methods
for a description of this mouse line). We then silenced the
LHb with an adeno-associated virus (AAV) that expressed a
Cre-dependent tetanus-toxin-light-chain (TeLC) transgene
[25]. This toxin cleaves the vesicle-associated membrane pro-
tein synaptobrevin-2, which plays a key role in neurotransmitter
release [26]. We injected AAV-flex-GFP-TeLC bilaterally into
the LHb of Grm2-Cre mice to selectively block neurotransmis-
sion from these neurons (LHb-TeLC mice) (Figures 1B, S1,
S2A, and S2B). Control mice were generated by bilaterally in-
jecting AAV-flex-GFP into Grm2-Cre mice (LHb-GFP mice).
LHb-TeLC mice had no overt neurological symptoms, and their
weights (30.2 ± 4.3; mean ± SD) did not differ (p = 0.12; un-
paired two-tailed t test) from LHb-GFP controls (33.2 ± 4.8;
mean ± SD). The Cre-dependent transgene expression in cell
bodies was confined to the LHb (Figures 1B and S1). There
was no cell body expression in the MHb, or in midline thalamic
structures. GFP-TeLC transgene expression was seen in
Grm2-Cre neurons throughout the LHb. To further visualize2 Current Biology 28, 1–8, February 19, 2018axons from these neurons, we also in-
jected AAV-flex-ChR2-EYFP (LHb-ChR2
mice) (Figures S2C and S2D). We tracedthe projections from these neurons to their targets (Figures S2
and S3). Many axonal fibers in the LHb-TeLC and LHb-ChR2
mice were strongly positive, including the fasciculus retro-
flexus, the main fiber bundle from the LHb (Figures S2 and
S3). In addition to the anticipated projections to the ventral
tegmental area (VTA), substantia nigra, and dorsal raphe areas
(Figure S2), there were also unexpected GFP-TeLC- and ChR2-
EYFP-positive fibers outlining the midline thalamic nuclei
(including the central lateral, the central medial, the intermedio-
dorsal, and the reunions nuclei), in the lateral hypothalamus, in
the preoptic hypothalamus, especially the median preoptic nu-
cleus, the septal hippocampal nucleus, the dorsal-lateral
caudate-putamen (Figures S2 and S3), and in the prefrontal
cortex (Figure S3), as well as in the mammillary area (Figure S2).
Thus Grm2-Cre neurons in the LHb project more widely than
anticipated, and their firing is likely to influence many brain
regions.
To determine the transmitter phenotype, we patched EYFP-
positive LHb neurons in acute slices from LHb-ChR mice,
extracted their mRNA, and did real-time PCR assays (Fig-
ure S3A). EYFP-positive (Grm2-Cre) LHb neurons, and also
non-EYFP-expressing LHb neurons, expressed the Vglut2
gene, which encodes a glutamate vesicular transporter, but
many cells also expressed low levels of the GABAergic
Gad1(Gad67) gene (Figure S3). In a parallel assay to confirm
specificity of the PCRs, neocortical pyramidal neurons
randomly chosen and patched from the same slices did not
contain Vglut2 or Gad1 transcripts (Figure S3). To confirm
Figure 2. Silencing Output from Grm2-Cre
Neurons in the LHb Reduces Propofol-
Induced Sedation and LORR
(A) Propofol-induced LORR at 7 mg/kg (i.v.) was
blocked in LHb-TeLC mice (unpaired two-tail t test;
p = 1.13 107, t = 6.69, df = 34, n = 14 LHb-GFPmice
and 22 LHb-TeLC mice).
(B) Propofol caused a nearly 3-fold rightward shift in
the quantal dose-response curve (p = 0.009, unpaired
two-tailed t test, t = 70, df = 1).
(C) Propofol-induced (7 mg/kg) sedation in control
LHb-GFP mice (two-way ANOVA; p < 1.0 3 104,
F17,414 = 4.80, n = 11 saline and 14 propofol).
(D) Lack of propofol-induced (7 mg/kg) sedation in
LHb-TeLCmice (two-way ANOVA; p = 0.26, F17,731 =
1.19, n = 21 saline and 23 propofol).
(E) Propofol-induced (7 mg/kg) changes in the global
EEG wavelet power spectra from control LHb-GFP
mice (p = 0.02, paired two-tailed t test, n = 7 saline
and 7 propofol),
(F) Propofol (7 mg/kg) inducedmuch smaller changes
in the global EEGwavelet power spectra in LHb-TeLC
mice (p = 0.03, paired two-tailed t test, n = 7 saline
and 7 propofol).
(G) The effects of propofol on the average wavelet
power spectrum for LHb-GFP mice (n = 7) showing
the large increases in EEG power. Propofol was in-
jected at 50 s.
(H) The effects of propofol on the average wavelet
power spectrum for LHb-TeLC mice (n = 7) showing
the much smaller increases in EEG power. Propofol
was injected at 50 s. Symbols in (A), (C), and (D) are
means ± SEMs.
(E and F) Lines and error envelopes represent the
mean and SEM, respectively.
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inant neurotransmitter, and that GFP-TeLC blocked their
transmitter release, we injected either AAV-flex-ChR2-EYFP
alone into the LHb of Grm2-Cre mice (LHb-ChR2 mice) or
co-injected AAV-flex-ChR2-EYFP and AAV-flex-GFP-TeLC
(LHb-ChR2/LHb-TeLC mice). We then made acute brain slices
from several example projection regions, containing either
prefrontal cortex (PFC) or dorsal caudate-putamen, from
both groups of mice. In slices from these areas of LHb-ChR2
mouse brains, light pulses evoked excitatory postsynapticcurrents (EPSCs) (in 100% of cells), but
not if the light pulses were given in the
presence of the AMPA/NMDA receptor
antagonists 6-cyano-7-nitroquinoxaline-
2,3-dione (CNQX) and AP-5 (Figures S3F
and S3G). Thus, these LHb neurons are
glutamatergic. In slices from PFC and
dorsal caudate-putamen of LHb-ChR2/
LHb-TeLC mice, light stimulation evoked
EPSCs in only about 35% of neurons
(Figure S3H), presumably because the
neurons that gave rise to these axons
had not been co-transduced with the
two AAVs. But overall, the large decrease
in evoked EPSCs in LHb-ChR2/LHb-
TeLC confirmed that TeLC expression inGrm2-Cre neurons in the LHb blocks their neurotransmitter
release.
Blocking Output from the LHb Greatly Diminishes the
Sedative Effects of Propofol
We next investigated the effects of bolus doses of propofol suffi-
cient to induce sedation and LORR, but not deep anesthesia. At
a dose of 7 mg/kg (i.v.) LHb-GFP mice had LORR that lasted on
average for 90 ± 16 s (mean ± SEM; n = 14) (Figure 2A). LHb-
TeLC mice by contrast were virtually unresponsive to this doseCurrent Biology 28, 1–8, February 19, 2018 3
Figure 3. Pharmacogenetic Stimulation of
Grm2-Cre LHb Neurons Reduces Locomo-
tor Activity
(A) Bilateral injection of AAV-flex-hM3Dq-
mCHERRY into the LHb region of Grm2-Cremice;
scale bar, 200 mm. Expression of the receptor,
detected with mCherry immunocytochemistry,
was restricted to cells in the LHb. DG, dentate
granule cells; 3V, third ventricle.
(B) Bath application of 5 mM CNO in a brain slice
preparation led to an increase in resting mem-
brane potential of 9.0 ± 3.1 mV from 59.2 ± 3.5
to 50.2 ± 3.5 mV (paired two-tailed t test; n = 8
neurons, 3 mice; p = 0.023, t = 2.88, df = 7).
Resting membrane potential was calculated as an
average voltage (sampled every 200 ms) between
1 and 3min immediately before bath application of
CNO and at the peak of the effect 5–10 min after
drug administration.
(C) Locomotor speed was recorded in an open
field for 20 min, 20 min after CNO (5 mg/kg, i.p.)
injection or saline injection, and the speed was
reduced approximately 2-fold (paired two-tailed
t test; n = 10 mice; p = 2.263 104, t = 5.91, df = 9)
following CNO injection.
(B and C) Symbols are mean ± SEM.
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The quantal dose-response curve for propofol (Figure 2B) was
shifted to the right by about a factor of 3. Even after they recovered
from LORR, the locomotion of the LHb-GFP mice was impaired
(p < 104) for several minutes following propofol injection
compared with saline injected controls (Figure 2C), whereas the
locomotion of the LHb-TeLC mice was unaffected (p > 0.3) (Fig-
ure 2D). These differences in propofol sensitivity were reflected
in the EEG: in LHb-GFP control mice, a propofol injection
compared with saline elicited a nearly 3-fold increase in power,
with increases in bothdelta frequency power, aswell as producing
an increase in the power of a broad range of frequencies >10 Hz
extending to the gamma range, 30–40 Hz (Figure 2E), as we found
in rats [10]. By contrast, in LHb-TeLC mice, propofol injection,
when compared with a saline injection, produced much smaller
(60% increase) changes in delta frequency power, as well as at
higher frequencies (Figure 2F), although the overall increase in po-
werwasstill significant (p=0.034).Wavelet spectra asa functionof
time (Figures 2G and 2H) show that these increases in EEG power
occur almost immediately following propofol injection (at 50 s).
Stimulating Output from the LHbReducesMotor Activity
Acute electrical stimulation of the LHb in cats strongly induces
NREM sleep [27], yet on the other hand, lesioning the LHb4 Current Biology 28, 1–8, February 19, 2018in rats slightly decreases the amount
of REM sleep and theta power in the
EEG without affecting NREM sleep
[28]. There are, however, many sub-
types of glutamatergic projection
neuron in the LHb [29, 30]; for example,
only subsets of LHb neurons convey er-
ror prediction [1]. Similarly, it is feasible
that only certain neuronal subtypes inthe LHb are responding to propofol. To corroborate our
results obtained with propofol, we tested whether pharmaco-
genetic excitation of Grm2-Cre neurons in the LHb mimicked
the effects of propofol. We bilaterally injected AAV-flex-
hM3Dq-mCHERRY into the LHb of Grm2-Cre mice (LHb-
hM3Dq mice, Figure 3A); hM3Dq receptor expression was
confined to the LHb (Figure 3A). The metabotropic hM3Dq
receptor, when activated by its ligand clozapine-N-oxide
(CNO), is excitatory [31]. In acute slices containing LHb,
we patch-clamped neurons expressing the hM3Dq receptor
(identified by mCHERRY fluorescence). CNO application
caused a gradual depolarization (9.0 ± 3.1 mV; n = 8) (Fig-
ure 3B), often resulting in a train of action potentials. System-
ically injecting LHb-hM3Dq mice with CNO decreased their
movement 2-fold (p = 2.3 3 104; n = 10) (Figure 3C)
compared with saline injections. During the time that this
reduction in mobility was recorded (20–40 min after CNO in-
jection), there was no significant increase in the percentage
of time scored as NREM sleep (p = 0.52). Because CNO is
metabolized to clozapine, which also acts as a ligand at
hM3Dq receptors [32], we checked that CNO (5 mg/kg i.p.)
did not significantly affect motor activity in LHb-mCherry
mice compared to saline injection (p = 0.44, two-tailed paired
t test n = 5).
Figure 4. Silencing Output from Grm2-Cre
Neurons in the LHb Causes Sleep Fragmen-
tation
(A) Percentage of time during wake, NREM, and
REM was identical between LHb-GFP and LHb-
TeLC mice (two-way ANOVA; wake: p = 0.96,
F23,456 = 0.53; NREM: p = 0.96, F23,456 = 0.53;
REM: p = 0.84, F23,456 = 0.71.
(B) Four left-hand panels: the number of episodes
of wake, NREM, and sleep (defined as a consoli-
dated period of NREM and REM) was larger in
LHb-TeLC mice (n = 9) than Lhb-GFP mice
(n = 13), although their durations were generally
proportionately shorter (unpaired two-tail t tests).
These changes were greater during ‘‘lights ON’’
(wake episodes: p = 6.7 3 109, t = 9.56; wake
duration: p = 9.33 105, t = 4.87; NREM episodes:
p = 2.23 106, t = 6.54; NREM duration: p = 1.73
106, t = 6.66; sleep episodes: p = 3.5 3 108,
t = 8.63; sleep duration: p = 1.8 3 105, t = 5.58;
df = 20) compared with ‘‘lights OFF’’ (wake epi-
sodes: p = 1.7 3 103, t = 3.63; wake duration:
p = 0.18, t = 1.38; NREM episodes: p = 6.43 103,
t = 3.05; NREM duration: p = 3.9 3 104, t = 4.26;
sleep episodes: p = 3.6 3 103, t = 3.29; sleep
duration: p = 7.8 3 103, t = 2.95; df = 20). There
were no changes (unpaired two-tail t test) in either
episode number or duration for REM for either
‘‘lights ON’’ (p = 0.26, t = 1.17 and p = 0.38,
t = 0.09, df = 20) or ‘‘lights OFF’’ (p = 0.91, t = 0.11
and p = 0.38, t = 0.90, df = 20). Two right-hand
panels: cumulative distributions for wake and
NREM bout durations during ‘‘lights ON.’’
(C) Blocking the output of LHb Grm2-Cre neurons
with TeLC greatly increased wake-NREM and
NREM-wake transitions (red arrows) during both
‘‘lights ON’’ (p = 7.03 106, t = 5.92 and p = 1.43
104, t = 4.62, respectively; df = 21) and ‘‘lights
OFF’’ (p = 0.01, t = 2.58 and p = 8.0 3 103,
t = 2.92, respectively, df = 21) but also caused an
increase in REM-wake transitions during ‘‘lights
ON’’ (p = 7.0 3 103, t = 2.98, df = 21, red arrow).
The values by the arrows are average transitions
per hour.
(D–F) The orexin receptor antagonist, almorexant,
largely reversed the sleep fragmentation that was
observed in the LHb-TeLC mice. During the 12 hr
after i.p. injection of almorexant (30 mg/kg) into
LHb-TeLC mice, (D) the percentage of time in the
wake state was reduced (repeated-measures
ANOVA, Ftreatment(1,96) = 8.27, p = 0.005), (E)
the percentage of time in the NREM state
was increased (repeated-measures ANOVA,
Ftreatment(1,96) = 9.45, p = 0.003), but (F) there was
no change in the time spent in REM.
(G) The number of wake (p = 1.4 3 104), NREM
(p = 0.059), and sleep (consolidated NREM+REM)
episodes (p = 0.002) were reduced, with no
change in the number of REM episodes.
(H) Moreover, the average durations of wake,
NREM (p = 0.035), and sleep (p = 2.1 3 104)
increased, with no change in the average duration
of REM episodes (n = 4 vehicle and n = 6
almorexant). Where error bars are shown they
represent SEM.
See also Figure S4.
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Fragmentation of NREM Sleep
Because manipulations of anesthetic targets often affect sleep
architecture [16, 33], we next explored whether chronically
silencing LHb Grm2-Cre neurons affected natural sleep over
24 hr (Figure 4). LHb-TeLC mice did not differ from LHb-GFP
mice in their overall time spent in wake, NREM, or REM sleep
(p > 0.8; n = 9–11); both groups of mice had a typical 24-hr activ-
ity profile, with less wakefulness during ‘‘lights ON’’ (Figure 4A),
although the delta power during NREM in LHb-TeLC mice was
slightly lower than that in LHb-GFPmice (p = 0.02) (Figure S4A).
However, there was a large difference in sleep consolidation
(Figures 4B, S4B, and S4C). The number of wake and NREM
episodes was substantially higher in LHb-TeLC mice compared
with LHb-GFP mice, particularly during ‘‘lights ON,’’ but the
durations of these states were proportionately reduced (Figures
4B, S4B, and S4C). Taking this analysis further, the duration of
entire sleep episodes (defined as REM plus NREM in a contin-
uous block) decreased strongly, particularly during ‘‘lights
ON,’’ but their number increased proportionately (Figures 4B,
S4B, and S4C). REM sleep frequency and duration was
unchanged in LHb-TeLC mice compared with LHb-GFP mice,
but in LHb-TeLC mice, there was a high number of REM-wake
transitions that were not apparent in control mice (Figure 4C).
Thus, LHb-TeLCmice had a severely fragmented pattern of nat-
ural NREM sleep.
Why should the sleep fragmentation phenotype be greatest
during the ‘‘lights-ON’’ period? The LHb receives afferents
from both the suprachiasmatic nucleus that houses the master
circadian clock and the pineal gland [3]. LHb neurons fire when
light activates the retina [34] but also maintain an intrinsic circa-
dian rhythmicity in action potential firing in acute brain slices
[34, 35]. Thus, LHb activity could help maintain sleep during
daylight, when mice are resting more. Intriguingly, we found
that the sleep fragmentation phenotype of LHb-TeLC mice was
largely reversed by systemic administration of the dual orexin
receptor antagonist almorexant (Figures 4D–4H). Almorexant
caused an overall reduction in waking that lasted several hours
(Figure 4D) and a corresponding increase in NREM sleep (Fig-
ure 4E), with no significant changes in REM (Figure 4F). These
changes were due to the number of wake and sleep (consoli-
dated NREM + REM) episodes decreasing, but the durations of
NREM and sleep increasing (Figures 4G and 4H). These results
suggest that excessive activation of the orexin system contrib-
utes to the sleep-wake fragmentation in LHb-TeLC mice. This
is perhaps because of failure to excite GABA neurons that inhibit
orexin neurons and is consistent with the presence of LHbGrm2-
Cre axons in the lateral hypothalamic area (Figure S2). This
explanation is consistent with the observation that in mice that
overexpress orexin [36], sleep is fragmented with significantly
more wake and NREM episodes, but with reduced durations,
particularly during ‘‘lights ON.’’
What Role Does the Propofol-Induced Excitation of the
LHb Play in Sedation?
It has been hypothesized that the LHb has diverse roles, all
united by a common theme of motor suppression [3]. The LHb
is a glutamatergic hub [3, 5] that receives input from diverse fore-
brain regions (e.g., the PFC, basal ganglia, and preoptic and6 Current Biology 28, 1–8, February 19, 2018lateral hypothalamus [3, 5]) and projects to GABAergic neurons
of the rostromedial tegmental nucleus [37], a nucleus at the
caudal end of the VTA. Trans-synaptic retrograde tracing has
shown that GABAergic neurons throughout the VTA receive a
disproportionately large input from the LHb [38], and this could
provide a powerful inhibitory control of motor responses [4] by
inhibiting dopamine and serotonin neurons [2, 3]. In keeping
with its diversemodulatory roles, dopamine also supports wake-
fulness [39]. Selectively activating dopamine neurons optoge-
netically in a downstream target of the LHb, the VTA, induces
both consolidated wakefulness [39] and also prompt wakening
from general anesthesia [40].
The above findings are certainly consistent with our observa-
tion that selective excitation of the LHb reduces motor activity.
Because blocking LHb glutamatergic output prevents propo-
fol-induced loss of muscle tone (LORR) and also reduces the
propofol-induced enhancement in EEG power, this implies the
LHb must be able to modulate the thalamocortical coherence
that is a hallmark of propofol’s sedative and anesthetic effects.
It is most commonly assumed that sedation is a consequence
of anesthetics activating, or potentiating, inhibitory circuits.
Our findings, however, show that the activation of an excitatory
pathway is mechanistically essential for propofol-induced
sedation.
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Antibodies
Anti-EGFP rabbit polyclonal antibody Thermo Fisher Scientific A6455; RRID: AB_221570
Anti-mCherry mouse monoclonal antibody Clontech 632543; RRID: AB_2307319
Anti-cFos rabbit polyclonal antibody Synaptic System 226003; RRID: AB_2231974
Alexa Fluor 488 goat anti-rabbit IgG Molecular Probes A11034; RRID: AB_2576217
Alexa Fluor 594 goat anti-mouse IgG Molecular Probes A11005; RRID: AB_141372
Alexa Fluor 594 donkey anti-rabbit IgG Life Technologies ab150076; RRID: AB_2340621
Alexa Fluor 555 streptavidin Conjugate Thermo Fisher Scientific S32355; RRID: AB_2571525
Bacterial and Virus Strains
AAV-flex-GFP-TeLC [41] N/A
AAV-flex-EGFP This paper N/A
AAV-flex-ChR2(H134R)-EYFP This paper N/A
AAV-flex-hM3Dq-mCHERRY [42] N/A
Chemicals, Peptides, and Recombinant Proteins
Sodium deoxycholate Sigma-Aldrich D5670
Benzonase endonuclease Sigma-Aldrich E1014
Isoflurane Zoetis 50019100
Injectable Propofol Fresenius Kabi https://www.fresenius-
kabi.com/fi/documents/
SmPC_Propofol_2__MCT.pdf
Clozapine N-Oxide Tocris 4936
Pentobarbital Sodium solution JML M042
Paraformaldehyde 16% Alfa Aesar 30525-89-4
Triton X-100 Sigma-Aldrich T8787
Normal goat serum Vector Laboratories S-1000
2,6-Diisopropylphenol Aldrich D12660-8
CNQX Tocris 0190
D-AP5 Tocris 0106
Biocytin Sigma B4261
Critical Commercial Assays
Single Cell-to-CT Kit for qRT-PCR Thermo Fisher Scientific 4458236
Experimental Models: Cell Lines
HEK293 cells Sigma-Aldrich 85120602; RRID: CVCL_0045
Experimental Models: Organisms/Strains
Tg(Grm2-cre)MR90Gsat/Mmcd GENSAT MR90-CRE
Oligonucleotides
Grm2(34611) F 50-GGCAGCCACTCTTTGGTTC
TACTC-30
MMRRC 034611-UCD
CreGS-R1 50-CGGCAAACGGACAGAAGCATT-30 MMRRC 034611-UCD
Vglut2/solute carrier family 17 gene expression
assays
Thermo Fisher Scientific Mm00499876_m1
Gad67/glutamate decarboxylase gene expression
assays
Thermo Fisher Scientific Mm04207432_g1
18S ribosomal RNA gene expression assays Thermo Fisher Scientific Mm04277571_s1
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REAGENT or RESOURCE SOURCE IDENTIFIER
Recombinant DNA
pAAV-FLEX-GFP plasmid Addgene 28304
pAAV-EF1a-double floxed-hChR2(H134R)-
EYFP-WPRE-HGHpA
Addgene 20298
pAAV-hSyn-DIO-hM3D(Gq)-mCherry Addgene 44361
Adenovirus helper plasmid pFD6 Donated by M Klugmann [43] N/A
AAV helper plasmid pH21 (AAV1) Donated by M Klugmann [43] N/A
AAV helper plasmid pRVI (AAV2) Donated by M Klugmann [43] N/A
Software and Algorithms
Spike2 Cambridge Electronic Design http://ced.co.uk/products/spkovin
MATLAB MathWorks https://uk.mathworks.com/
Activity Monitor Version 5 for mice Medical Associates http://www.med-associates.com/
product-category/activity-software/
WinWCP, Version 4.1.2 Strathclyde Electrophysiology
Software
http://spider.science.strath.ac.uk/
sipbs/showPage.php?page=software_ses
WinEDR, Version 3.0.9 Strathclyde Electrophysiology
Software
http://spider.science.strath.ac.uk/
sipbs/showPage.php?page=software_ses
SDS 2.1 Thermo Fisher Scientific https://www.thermofisher.com/uk/en/
Prism6 GraphPad Software https://www.graphpad.com
Origin OriginLab https://www.originlab.com/
Other
1-ml HiTrap Heparin column Sigma-Aldrich 5-4836
Amicon Ultra-4 Millipore UFC810024
Angle Two stereotaxic frame Leica Microsystems N/A
Hamilton microliter 10-ml syringes Hamilton 701
Custom made 33-gauge stainless steel needle Hamilton 7803-05
Borosilicate glass capilaries Harvard Apparatus GC150F-10
Neurologger 2A [44, 45] N/A
Vibratome Leica Microsystems VT1000S
Vibratome tissue slicer Campden Instruments 7000smz
Blue (470 nm) collimated LED Thorelabs M470L3-C1
StepOnePlus Real-Time PCR Systems Thermo Fisher Scientific 4376600
Uplight Microscope Olympus BX51W1
Upright Microscope Scientifica S-Scope
SciCam Pro Scientifica 100918
Four wavelength high power LED source Thorelabs LED4D
Multiclamp 700B amplifier Molecular Devices N/A
DAD National Instruments BND-2100
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice
All experiments were performed in accordance with the United Kingdom Home Office Animal Procedures Act (1986), and had local
ethical approval. The Grm2-Cremouse line was generated by GENSAT and obtained from the Mouse Mutant Resource Center (UC
Davis, Davis, CA), stock Tg(Grm2-cre)MR90Gsat/Mmcd (The Gene Expression Nervous System Atlas - GENSAT - Project,
NINDS Contracts N01NS02331 & HHSN271200723701C to The Rockefeller University, New York, NY). The line was generated bye2 Current Biology 28, 1–8.e1–e5, February 19, 2018
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(2018), https://doi.org/10.1016/j.cub.2017.12.050pronuclear injection of a BAC transgene containing a Cre recombinase reading frame inserted into the metabotropic glutamate
receptor 2 gene [41]. We maintained the line as heterozygotes. Genotyping primers for the Grm2-Cre line were Grm2(34611)F
(50-GGCAGCCACTCTTTGGTTCTACTC-30) and CreGS-R1 (50-CGGCAAACGGACAGAAGCATT-30); a 375 bp product indicated the
transgene (protocol and primer sequences recommended by the Mouse Mutant Resource Centre, https://www.mmrrc.org/). Male
mice (3 - 5 months old) were kept on a 12:12 light:dark cycle, 22 ± 1C, 50% relative humidity, at a maximum of four animals per
cage, with free access to food and water. Following surgery, mice were kept singly housed. Behavioral experiments, except where
specified otherwise, were performed during the ‘‘Lights OFF’’ period.
METHOD DETAILS
AAV transgenes
The AAV-flex-GFP-TeLC transgene plasmid was described previously [25]. The GFP protein is fused to the N terminus of TeLC. The
AAV-flex-EGFP transgene was Addgene plasmid 28304 (gift from Edward Boyden, MIT, Cambridge, USA). The AAV-flex-
ChR2(H134R)-EYFP transgene was a gift from Karl Deisseroth (Addgene plasmid 20298). This expresses the humanized ChR2
gene with histidine 134 changed to arginine, to make larger currents; EYFP is fused to the C terminus of ChR2, which also makes
it a good substrate for axonal transport. The AAV-flex-hM3Dq-mCHERRY transgene was a gift from Bryan L. Roth (Addgene plasmid
44361) [42]. The mCherry protein is fused to the C terminus of hM3Dq.
Generation of recombinant AAV particles
All AAV transgenes were packaged into AAV capsids (mixed serotype 1 & 2, 1:1 ratio of AAV1 and AAV2 capsid proteins with AAV2
ITRs) [43]. HEK293 cells (obtained from the European Collection of Cell Cultures (ECACC) via Sigma-Aldrich) were co-transfected,
using the calcium phosphate method, with AAV transgene plasmid, the adenovirus helper plasmid pFD6, and the AAV helper plas-
mids pH21 (AAV1), and pRVI (AAV2) [43]. 60–65 hours after transfection, cells were washed in 1 x PBS, and pelleted; pellets were
resuspended in 150 mMNaCl, 20 mM Tris pH 8.0. Then sodium deoxycholate (Sigma #D5670) and benzonase endonuclease (Sigma
#E1014) were added and incubated at 37C for 1 hr. After incubating, cell debris were removed by centrifugation and AAV particles
were purified from the supernatant by passing over a heparin column (1 mL HiTrap Heparin columns, Sigma #5-4836), which binds
the AAV particles. The column was pre-equilibrated with 10 mL 150 mM NaCl, 20 mM Tris pH 8.0. Then the supernatant was loaded
onto the column at a flow rate of 200 ml/min; the column was washed with 20 mL 100 mM NaCl, 20 mM Tris pH 8.0 and virus was
eluted off the column as follows: 1 mL 200 mM NaCl, 20 mM Tris pH 8.0 (discarded), 1 mL 300 mM NaCl, 20 mM Tris pH 8.0
(discarded), 1.5 mL 400 mM NaCl, 20 mM Tris pH 8.0 (collected), 3 mL 450 mM NaCl, 20 mM Tris pH 8.0 (collected), 1.5 mL
500 mM NaCl, 20 mM Tris pH 8.0 (collected). After purification, AAV particles were concentrated using Amicon Ultra-4
(100000MWCO, #UFC810024, Millipore, Watford, Hertfordshire, UK) at 2000 g for 10 min. The concentrator was twice refilled
with 3.5 mL of 0.9% NaCl. Elutions were removed to a sterile tube, and 250 mL of 0.9% NaCl were added. AAV was aliquoted
and stored at –80C.
Stereotaxic injections of AAV
All the AAV-injection experiments used adult male heterozygote Grm2-Cre mice, 8–12 weeks old. Mice were anesthetized with 2%
isoflurane in oxygen by inhalation and mounted into a stereotaxic frame (Angle Two, Leica Microsystems, Milton Keynes, Bucking-
hamshire, UK). AAV was injected using Hamilton microliter #701 10 mL syringes with a 33-gauge stainless steel needle (Point style 3,
length 1.5 cm, Hamilton), back loaded with mineral oil and AAV mixture (1:1 with 20% mannitol) in the tip. For the LHb-ChR2/LHb-
TeLCmice, the two AAVs, AAV-flex-ChR2-EYFP and AAV-flex-TeLC-EGFP were mixed 1:1 prior to injection. The coordinates of the
(bilateral) injection sites according to the digital atlas of the Leica apparatus were relative to Bregma: AP,1.70; ML -/+ 0.44; DV was
consecutive, starting +2.90 (1/3 volume), +2.85 (1/3 volume), +2.80 (1/3 volume). To make the LHb-ChR2/LHb-TeLC mice, a total
volume of 1 mL of AAV was divided into three aliquots for each side of the brain; to generate the LHb-hM3Dq mice, we used a total
of 0.6 mL per brain side, again divided into three aliquots for each consecutive injection. Mice that had been injected with AAVs were
allowed 1 month to recover in their home cages and for the viral transgenes to adequately express before being fitted with Neuro-
logger 2A devices (see below) and undergoing behavioral experiments.
EEG and EMG recordings and sleep scoring
For non-tethered EMG and EEG recordings, mice were chronically implanted with skull screw electrodes (–1.5mmBregma, +1.5mm
midline – first recording electrode; +1.5 mmBregma, –1.5mmmidline – second recording electrode; –1 mm Lambda, 0mmmidline –
reference electrode) to measure cortical EEG. A pair of stainless steel EMG electrodes was implanted in dorsal neck muscle. The
electrical signals were recorded on a wireless electronic recording device (Neurologger 2A) as described previously [44, 45]. Four
data channels could be recorded at a sampling rate of 200 Hz and waveforms visualized using Spike2 software (Cambridge
Electronic Design, Cambridge, UK) or MATLAB (MathWorks, Cambridge, UK). The EEG was high-pass filtered (1 Hz, 3dB) using
a digital filter and the EMG was band-pass filtered between 5-48 Hz (3dB). Power in the delta (0-4 Hz) and theta (6-10 Hz) bands
were calculated, together with the RMS value of the EMG signal (averaged over a bin size of 5 s), and these were used to define theCurrent Biology 28, 1–8.e1–e5, February 19, 2018 e3
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blocks of time. The Fourier transform power spectra were normalized such that the total area under the spectra for the saline controls
was unity.
Assay for sedation
Propofol (Fresenius Kabi, Runcorn, Cheshire, UK), was delivered via tail-vein injection (i.v.). CNO (5 mg/kg, Cat. No. 4936, Tocris,
Avonmouth, Bristol, UK) was administered by intraperitoneal injection (i.p.). For propofol-induced sedation, animals, fitted with
Neurologger 2A devices, were placed immediately after i.v. injection in an activity cage to assess locomotor activity. For CNO exper-
iments, mice were placed in the activity cages 20 minutes after i.p CNO injections (Activity Monitor Version 5 for mice, Medical
Associates, St. Albans, VT). All mice were videoed. The EEG of animals was simultaneously recorded (see above).
Assay for LORR
Propofol was delivered via tail-vein injection and animals, fitted with Neurologger 2A devices [44], were tested for loss of righting
reflex (LORR) by placing them gently on their backs [45]. Animals were scored as positive for LORR if they made no obvious attempt
to right themselves. All mice were videoed. The EEG of animals was simultaneously recorded using Neurologger 2A devices [44, 45]
(see above).
Immunohistochemistry
Under deep pentobarbital anesthesia (100 mg/kg body weight; i.p.), mice were fixed by transcardial perfusion with 4% paraformal-
dehyde in PBS, pH 7.4. Brains were removed and 35-mm-thick coronal sections cut using a Leica VT1000S vibratome. Free-floating
sections were washed in PBS three times for 10 minutes, permeabilized in PBS plus 0.4% Triton X-100 for 30 min, blocked by incu-
bation in PBS plus 4%normal goat serum (NGS), 0.2%Triton X-100 for 1 h (all at room temperature) and subsequently incubated with
an EGFP antibody (, rabbit, 1:1000, A6455, Thermo Fisher Scientific, Loughborough, Leicestershire, UK) and/or a mCHERRYmono-
clonal antibody (mouse, 1:2000, #632543, Clontech, Mountain View, CA). Primary antisera were diluted in PBS plus 2%NGS (normal
goat serum) overnight at 4C. The next day, incubated slices were washed three times (each lasting 10 minutes), in PBS and then
incubated for 2 h at room temperature in PBS plus 1% NGS with a 1:1000 dilution of a Alexa Fluor 488 goat anti-rabbit IgG (H+L)
(1:1000, A11034, Molecular Probes, Eugene, OR) or Alexa Fluor 594 goat anti-mouse IgG (H+L) (1:1000, A11005, Molecular Probes),
and subsequently washed there times in PBS for 10 min at room temperature. The sections were mounted on slides and coverslip-
ped. For cFOS expression the primary antibody was cFOS (rabbit, 1:1000, Cat. No. 226003, Synaptic System), the secondary anti-
body was Alexa Fluor 594 donkey anti-rabbit IgG (1:1000, ab150076, Life Technologies).
Electrophysiology
Adult (3-6 months postnatal) mice were used, and brain slices were then prepared following cervical dislocation (in accordance with
UKHomeOffice guidelines). The brain was rapidly removed from the skull after decapitation and immersed in ice-cold slicing solution
composed of (in mM): 85 NaCl, 2.5 KCl, 1 CaCl2, 4 MgCl2, 1.25 NaH2PO4, 26 NaHCO3, 75 sucrose, 25 glucose, pH 7.4 when bubbled
with 95%O2/5%CO2. The cerebellum was removed and the remaining forebrain was then glued to the center of the vibratome stage
with the surface of the cut facing down. Coronal brain slices (250 mm thickness) were cut with a vibratome tissue slicer (Campden
Instruments, Loughborough, Leicestershire, UK) and immediately transferred to a holding chamber containing slicing artificial cere-
bral spinal fluid (ACSF) bubbledwith 95%O2/5%CO2. Once slicing was complete the holding chamber was then transferred to a 37
C
heat block for 10min, after which the slicing solution was exchanged for recording ACSF (in mM:NaCl 125, KCl 2.5, CaCl2 2, MgCl2 1,
NaH2PO4 1.25, NaHCO3 26, glucose 11, pH 7.4 when bubbled with 95%O2/5%CO2). The slices were incubated in the recording
ACSF at room temperature for at least another 20 minutes prior to electrophysiological recordings. For whole-cell current-clamp
recordings, the internal solution contained the following (in mM): 145 K-gluconate, 4 NaCl, 5 KCl, 0.5 CaCl2, 5 EGTA, 10 HEPES,
4 Mg-ATP, and 5 sucrose, pH 7.3, adjusted with KOH. Whole-cell recordings were performed with a Multiclamp 700B amplifier
(Molecular Devices, Wokingham, West Berkshire, UK). The analog output was low-pass filtered at 10 kHz and digitized at 20 kHz.
Data acquisition was performed using WinWCP (Version 4.1.2) and WinEDR (Version 3.0.9) kindly provided by John Dempster
(University of Strathclyde, UK). For optogenetic stimulation, a blue (470 nm) collimated LED (M470L3-C1, Thorlabs, Ely, Cambridge-
shire, UK) wasmounted to the back of theOlympus BX51W1microscope andwas controlled by self-programmed stimulus protocols
in WinEDR. For the acute slices containing the PFC and caudate putamen in the LHb-ChR2 and LHb-ChR2/LHb-TeLC mice, we
patched cells surrounded by a high density of ChR2-EYFP-positive fibers when viewed under primary fluorescence.
SINGLE CELL RT-PCR
Slices were transferred to a submersion recording chamber and were continuously perfused with fully oxygenated aCSF at room
temperature. Neurons were visualized using infra-red LED under an upright microscope (S-Scope, Scientifica, UK) equipped with
a 60x water immersion objective (1.0 numerical aperture) and a charge coupled device (CCD) video camera (SciCam Pro, Scientifica,
UK). Grm2-Cre EYFP-positive neurons were identified by their EYFP signal under fluorescence illumination (LED4D, Thorlabs,
coupled to YFP excitation filter). Borosilicate glass capillaries (1.5mm OD, 0.86mm ID, Harvard Apparatus, #GC150F-10) were au-
toclaved prior to pulling patching pipettes. Whole-cell patching was performed with a Multiclamp 700B amplifier (Molecular Devices,e4 Current Biology 28, 1–8.e1–e5, February 19, 2018
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nate, 5 NaCl, 10 HEPES, 0.1 EGTA, 2MgCl2, 2Mg-ATP, and 0.3 Na-GTP (pH 7.3, osmolality 285mOsm). 0.2%Biocytin was included
in the intracellular solution to identify the cell position and morphology. For RNA extraction, 0.5-1ml of intracellular solution was used
to fill the patch pipette to maximize RNA recovery. Cytoplasm was aspirated into the patch pipette, and expelled into a PCR tube
which contained lysate buffer. The single cell RT-PCR reactions were performed using the ‘‘Single Cell-to-CT Kit for qRT-PCR’’
(Cat. No. 4458236, Thermo Fisher Scientific). The mRNA levels in individual neurons were quantified by StepOnePlus Real-Time
PCR Systems (Thermo Fisher Scientific). PCR reactions were on triplicate cDNA samples. Predesigned gene expression
assays were used for Vglut2/solute carrier family 17 (Slc17a6-Mm00499876_m1) and Gad67/glutamate decarboxylase 1 (Gad1 -
Mm04207432_g1) genes and mouse 18S ribosomal RNA (Rn18s- Mm04277571_s1) genes. Data were evaluated with SDS 2.1 soft-
ware. The comparative threshold cycle (CT) method was used to determine the relative amounts of transcripts.
QUANTIFICATION AND STATISTICAL ANALYSIS
Prism6 and Origin were used for statistical analyses. No statistical methods were used to predetermine sample sizes, but our sample
sizes are similar to those reported in previous studies. Data collection and processing were randomized or performed in a counter-
balanced manner. Normality was tested by the Shapiro-Wilk test. Equal variances were assessed by F-test. Data are represented as
themean ±SEM, unless otherwise stated. For LORR, Fisher’s exact test or a two-tailed unpaired t test was performed. For the behav-
ioral experiments, two-way ANOVA (time and treatment factors) was performed with t tests where appropriate. P values are shown
when they are less than 0.05. Mice were excluded from the analysis if the histology did not confirm significant AAV transgene expres-
sion in the LHb, or if the transgene expression spread beyond the target region. Investigators were not blinded to treatment.Current Biology 28, 1–8.e1–e5, February 19, 2018 e5
